An Open-Label, 2-Part, Single Dose, Randomized Study to Evaluate the Pharmacokinetics of a Probe Formulation of MK-0663B (etoricoxib/tizanidine MR) in Healthy Adult Subjects.

Trial Profile

An Open-Label, 2-Part, Single Dose, Randomized Study to Evaluate the Pharmacokinetics of a Probe Formulation of MK-0663B (etoricoxib/tizanidine MR) in Healthy Adult Subjects.

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 23 Jun 2016

At a glance

  • Drugs Etoricoxib/tizanidine (Primary) ; Etoricoxib; Tizanidine
  • Indications Musculoskeletal pain; Rheumatic disorders
  • Focus Pharmacokinetics
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 12 Dec 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top